Recent Updates
Recently added Catalysts
TMDX Positive Sentiment

TransMedics to Present at Upcoming September Investor Conferences

Monday, August 25, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: TransMedics Group, Inc. will participate in two investor conferences in September 2025. The company will engage in a fireside chat at the Morgan Stanley Global Healthcare Conference and present at the Baird Global Healthcare Conference. These events aim to enhance investor relations and showcase TransMedics' advancements in organ transplant technology.
Price reaction · baseline $114.97 (2025-08-25 close) · hit after-hours · clean, no other TMDX news in the window
day 0 close
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • TransMedics is participating in two significant investor conferences.
  • The company is recognized as a leader in organ transplant technology.
  • The events provide an opportunity for increased visibility and engagement with investors.

Full Press Release Details

ANDOVER, Mass.,Aug. 25, 2025/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Morgan Stanley 23rdAnnual Global Healthcare Conference inNew YorkonMonday, September 8, 2025, at10:00 a.m. ESTand present at the Baird 2025 Global Healthcare Conference inNew YorkonTuesday, September 9, 2025, at12:15 p.m. EST.

Event: Morgan Stanley 23rdAnnual Global Healthcare ConferenceDate:Monday, September 8, 2025Time:10:00 a.m. EST

Event: Baird 2025 Global Healthcare ConferenceDate:Tuesday, September 9, 2025Time:12:15 p.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website athttps://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered inAndover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:Brian JohnstonLaine Morgan332-895-3222[email protected]

Frequently Asked Questions

When will TransMedics participate in the investor conferences?

TransMedics will participate on September 8 and 9, 2025.

What is the focus of TransMedics' technology?

TransMedics focuses on organ transplant therapy for end-stage organ failure.

Where can I watch the investor presentations?

The presentations will be available on the Investors section of TransMedics' website.

What are the names of the conferences TransMedics will attend?

The conferences are the Morgan Stanley Global Healthcare Conference and the Baird Global Healthcare Conference.

ShareAdd on Google
Tags: TMDX Viatris Investor Conferences Healthcare TransMedics investor conference healthcare organ transplant
Last updated: Aug 25, 2025

Biotech snapshot

Cash runway
$473M liquidity · $0M/mo burn
Low dilution risk